| Franklin Templeton International Services S.à r.l. | RV Sector Biotecnología | 38,68% | 4,37% | | | |
| Pictet Asset Management (Europe) SA | RV Sector Biotecnología | 32,99% | 3,57% | | | |
| Candriam | RV Sector Biotecnología | 29,39% | 6,65% | | | |
| Polar Capital LLP | RV Sector Biotecnología | 26,71% | 13,86% | | | |
| Medical Strategy GmbH | RV Sector Biotecnología | 22,07% | 6,79% | | | |
| Welzia Management SGIIC | RV Sector Biotecnología | 21,75% | — | | | |
| Sectoral Asset Management Inc | RV Sector Biotecnología | 21,52% | 3,54% | | | |
| Janus Henderson Investors | RV Sector Biotecnología | 20,49% | 15,74% | | | |
| Erste Asset Management GmbH | RV Sector Biotecnología | 17,66% | 4,39% | | | |
| UBS Asset Management (Europe) S.A. | RV Sector Biotecnología | 17,66% | 3,56% | | | |
| DNB Asset Management SA | RV Sector Biotecnología | 11,79% | — | | | |
| JPMorgan Asset Management (Europe) S.à r.l. | RV Sector Biotecnología | 9,58% | -8,88% | | | |
| Abante Asesores Gestión SGIIC | RV Sector Biotecnología | 8,06% | -4,99% | | | |
| DWS Investment GmbH | RV Sector Biotecnología | 7,41% | 3,94% | | | |
| Andbank Wealth Management SGIIC | RV Sector Biotecnología | 1,79% | — | | | |
